Format

Send to

Choose Destination
N Engl J Med. 2017 May 25;376(21):2001-2004. doi: 10.1056/NEJMp1700446.

Accelerated Approval and Expensive Drugs - A Challenging Combination.

Author information

1
From the Division of General Medicine and the Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, and the Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System - both in Pittsburgh (W.F.G.): and the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (A.S.K.).
PMID:
28538133
DOI:
10.1056/NEJMp1700446
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center